What it's used for
Nevirapine extended-release tablets are used in combination with other antiretroviral medications to treat human immunodeficiency virus infection in adults and pediatric patients 6 years and older with a body surface area of 1.17 square meters or greater.
Source: U.S. FDA-approved prescribing information (openFDA).
Typical dosing
Adult patients must follow a 14-day lead-in period with one 200 mg immediate-release tablet once daily, followed by one 400 mg extended-release tablet once daily. The extended-release tablets must be swallowed whole.
Dosing shown here is the general FDA-labeled range. Your prescribing clinician determines the exact dose, form, and schedule for you — this is not a substitute for medical advice.
Boxed warning / key safety info
Severe, life-threatening, and sometimes fatal liver damage has been reported, particularly in the first 18 weeks of treatment.
Common side effects
The most common adverse reaction in adult patients is rash, with a 3% incidence of drug-related rash during the lead-in period.
Covered strengths on the Tab $0 list
Covered at $0 with an active Tab membership when filled at a participating pharmacy nationwide or through mail order. A licensed clinician must prescribe the medication.
Related medications
Other everything else medications covered at $0 with an active Tab membership.